+86 18928918121
Accuray CyberKnife M6™ Robotic Radiosurgery System
√Omnidirectional Center-Focusing Technology
√Real-Time Image-Guided Dynamic Irradiation
√3D Conformal Dose Superposition
√Submillimeter Technical Accuracy
√Non-Invasive Cutting with Precise Sculpting
√Treatment of Benign and Malignant Tumors of The Whole Body
What is the CyberKnife?
The Cyberknife,also known as the “three-dimensional stereotactic radiosurgery robot”.The sixth generation of Ac- curay Cyberknife(M6)imported by our hospital is a fully digitalized whole-body stereotactic X-ray radiosurgery treatment device with a fully targeted multi-leaf grating.It belongs to the category of stereotactic radiotherapy (SRS/SBRT),which can track the patient’s position,tumor location,and patient respiratory motion feedback from three-dimensional directions during treatment.During the treatment process,it can make real-time corrections to the irradiation direction based on med- ical imaging guidance for the patient’s tumor target area(such as tumors).
Advantages and Features of CyberKnife
Non-invasive,painless,no anesthesia,short recovery period,low side effects
The treatment course is short,and only 1-5 times of irradiation are needed to kill the tumor,which can be completed in the outpatient department.
The system error is less than 0.95mm,which means that the tumor irradiation range is smaller and the normal tissue damage is less.
It can treat benign and malignant tumors in all parts of the body.
Fast imaging guidance,with unrivaled tumor tracking capabilities.
It largely eliminates the risk of postoperative complications and significantly improves
the quality of life of patients.
Advantages and Features of Cyberknife
CyberKnife,installed in 2019,radiotherapy license obtained on July 7,2020
CyberKnife is a radiosurgery device with real-time tracking radiotherapy technology.For intracranial and paraspinal tumors,skull tracking radiotherapy or spinal tracking radiotherapy can be used.For tumors in moving parts,dynamic tracking radiotherapy can be achieved through real-time imaging.The treatment is highly accurate,short treatment duration(1 to 5 fractions),and less side effects.
Our first Cyberknife case:July 10,2020
